| Index | Recent Threads | Unanswered Threads | Who's Active | Guidelines | Search |
 |
World Community Grid Forums
Category: Community
Forum: Chat Room
Thread: Free ACS Webinar |
| No member browsing this thread |
|
Thread Status: Active Total posts in this thread: 17
|
|
| Author |
|
|
littlepeaks
Veteran Cruncher USA Joined: Apr 28, 2007 Post Count: 748 Status: Offline Project Badges: 
|
This Thursday, June 25, 2015 from 2:00 - 3:00 PM EDT, there will be another free American Chemical Society (ACS) webinar, that may be of interest to the WCG Community:
----------------------------------------Accelerating CNS Positron Emission Tomography (PET) Ligand Discovery "PET ligands play important roles in drug discovery relating to the central nervous system. However, the discovery efforts of PET ligands have suffered from high attrition rates due to a demanding list of required attributes and a lack of guiding principles in ligand design and prioritization. Join Lei Zhang as he lays out a set of preferred parameters for CNS PET ligand design which has been derived from a systematic analysis of a PET ligand database. These preferred parameters have been applied prospectively applied to a number of programs within Pfizer, yielding successful PET ligands with reduced resources and timelines." This is Session 6 of the Drug Design and Delivery Symposium More info and a link to register for the webinar is available here .  [Edit 1 times, last edit by littlepeaks at Jun 24, 2015 3:17:46 AM] |
||
|
|
littlepeaks
Veteran Cruncher USA Joined: Apr 28, 2007 Post Count: 748 Status: Offline Project Badges:
|
This Thursday, July 30, 2015 from 2:00 - 3:00 PM EDT, there will be another free American Chemical Society (ACS) webinar, that may be of interest to the WCG Community:
----------------------------------------X-ray Crystallography in Drug Discovery "Jon Mason and Miles Congreve from Heptares will describe what protein-ligand X-ray data can do for your medicinal chemistry project. How these data can be interpreted and used to influence both the strategic direction of the work and to drive the design of compounds for synthesis will be discussed." This is Session 7 of the Drug Design and Delivery Symposium More info and a link to register for the webinar are available here. (If you've previously registered for drug-discovery seminars in this series, you do not need to register again). [Edit 1 times, last edit by littlepeaks at Jul 29, 2015 4:11:20 PM] |
||
|
|
littlepeaks
Veteran Cruncher USA Joined: Apr 28, 2007 Post Count: 748 Status: Offline Project Badges:
|
Today, August 27, 2015, from 2:00 - 3:00 PM EDT, there will be another free American Chemical Society (ACS) webinar, that may be of interest to the WCG Community:
----------------------------------------Choices and Trends in Solid Dosage Form Selection "The solid-state form of an active pharmaceutical ingredient impacts almost every aspect of a pharmaceutical program so consideration and selection of an appropriate form is key. Join Scott Trzaska and Ron Smith as they outline the pros and cons of the different forms and what to consider when selecting. ." This is Session 8 of the Drug Design and Delivery Symposium More info and a link to register for the webinar are available here . (If you've previously registered for drug-discovery seminars in this series, you do not need to register again). ---------------------------------------- [Edit 1 times, last edit by littlepeaks at Aug 27, 2015 3:02:23 PM] |
||
|
|
littlepeaks
Veteran Cruncher USA Joined: Apr 28, 2007 Post Count: 748 Status: Offline Project Badges:
|
This announcement is for those of you that are really into drugs (development of course). Chemical and Engineering News will be presenting its second annual virtual symposium highlighting groundbreaking research in drug discovery, chemical synthesis, informatics and drug development on Wednesday, September 16. This event will run from 8:00 AM EDT - 6:00 PM EDT.
Registration is free at http://engage.vevent.com/index.jsp?eid=782&seid=1319&code=CENEmail4 Since this symposium is for professionals, and I am retired, I put retired for my occupation, and "000-000-0000" for my business phone number and it accepted that. There is also a place to upload your resume. "Register now for free, then log in on September 16 to visit the virtual conference and trade show. It's like being there but without the cost or hassle of travel! Listen to 1-2 key talks or attend a stream of presentations throughout the day. -Participate in live Q&A sessions -“Walk the floor” in our virtual exhibition hall -Live-chat with peers and vendors in the booth -Download valuable resources -Re-watch your favorite talks There will also be a virtual career fair." "This year's keynote and event speakers are driving R&D inside leading commercial and academic institutions, including Merck, Pfizer, Genentech, Editas Medicine, BIND Therapeutics, Syros, The Scripps Research Institute , and many more. Among the many themes to be covered are: -Organic synthesis for novel drugs -Personalized and precision medicine -Structure-based drug design -Business and collaborative strategies -Gene regulation in cancer -Informatics in the R&D environment -Genome editing technologies" |
||
|
|
littlepeaks
Veteran Cruncher USA Joined: Apr 28, 2007 Post Count: 748 Status: Offline Project Badges:
|
Thursday, September 24, 2015, from 2:00 - 3:00 PM EDT, there will be another free American Chemical Society (ACS) webinar, that may be of interest to the WCG Community:
----------------------------------------Delivery Options to Support Dose Escalation in Preclinical Toxicology and Pharmacodynamic Activity Studies "Adjusting the dose of a medication does not always have the anticipated effect. At times, 'inactive ingredients' in drug formulations don’t always remain inactive, particularly when high doses are used to boost drug exposure. Join Evan Thackaberry as he shares how to develop an understanding of acceptable drug delivery approaches to support preclinical dose escalation " This is Session 9 of the Drug Design and Delivery Symposium More info and a link to register for the webinar are available here . (If you've previously registered for drug-discovery seminars in this series, you do not need to register again). [Edit 1 times, last edit by littlepeaks at Sep 24, 2015 3:13:57 AM] |
||
|
|
littlepeaks
Veteran Cruncher USA Joined: Apr 28, 2007 Post Count: 748 Status: Offline Project Badges:
|
Thursday, October 29, 2015, from 2:00 - 3:00 PM EDT, there will be another free American Chemical Society (ACS) webinar, that may be of interest to the WCG Community:
Pharmacokinetic Considerations in Drug Design and Development "The optimization of pharmacokinetic properties is crucial in the design of successful drug candidates. Tune in as Punit Marathe shares the key pharmacokinetic concepts including clearance, volume of distribution, half-life and protein binding will be highlighted along with their interpretation in achieving optimal in vivo profile." This is Session 10 of the Drug Design and Delivery Symposium More info and a link to register for the webinar are available here . (If you've previously registered for drug-discovery seminars in this series, you do not need to register again). |
||
|
|
littlepeaks
Veteran Cruncher USA Joined: Apr 28, 2007 Post Count: 748 Status: Offline Project Badges:
|
Thursday, November 19, 2015, from 2:00 - 3:00 PM EST, there will be another free American Chemical Society (ACS) webinar, that may be of interest to the WCG Community:
Prodrugs in Drug Discovery "Join us for the final broadcast of this year's symposium as John Higgins explains how prodrugs can be pursued early in discovery space in order to optimize drugs’ physicochemical and biopharmaceutical properties. Learn about the utility of prodrugs, their general properties and prerequisites for optimal performance." This is Session 11 and the last webinar this year of the Drug Design and Delivery Symposium More info and a link to register for the webinar are available here . (If you've previously registered for drug-discovery seminars in this series, you do not need to register again). |
||
|
|
|